• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    13.93 Down 0.88(5.94%) 4:00PM EDT
    |After Hours : 13.93 0.00 (0.00%) 4:58PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:14.81
    Open:14.90
    Bid:13.73 x 200
    Ask:13.93 x 700
    1y Target Est:35.10
    Beta:3.03099
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:13.84 - 15.22
    52wk Range:11.93 - 32.82
    Volume:1,479,955
    Avg Vol (3m):1,595,710
    Market Cap:1.37B
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CLDXDown 5.94%1.37B
    LLYDown 0.26%86.41B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):278.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.37
    Quarterly EPS Est (Sep-15) :-0.35
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback